---
title: "SDKX: The first subject has been enrolled in the Phase I clinical trial of GB18 injection"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263255772.md"
description: "Sinovac Biotech announced that its wholly-owned subsidiary, Shenzhen Sinovac Biotech Co., Ltd., has successfully completed the first subject enrollment and administration in the Phase I clinical study of \"GB18 Injection.\""
datetime: "2025-10-29T09:55:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263255772.md)
  - [en](https://longbridge.com/en/news/263255772.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263255772.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/263255772.md) | [繁體中文](https://longbridge.com/zh-HK/news/263255772.md)


# SDKX: The first subject has been enrolled in the Phase I clinical trial of GB18 injection

Sinovac Biotech announced that its wholly-owned subsidiary, Shenzhen Sinovac Biotech Co., Ltd., has successfully completed the first subject enrollment and administration in the Phase I clinical study of "GB18 Injection."

### Related Stocks

- [SDKX (688136.CN)](https://longbridge.com/en/quote/688136.CN.md)

## Related News & Research

- [Glenmark Pharmaceuticals to Launch Potassium Phosphates Injection in March](https://longbridge.com/en/news/279206533.md)
- [SSY Gets China Nod for Production, Registration of Vitamin Injection](https://longbridge.com/en/news/279036594.md)
- [Together Ever Introduces Revionyx™ to Support Healthy Aging in Premium Pet Nutrition](https://longbridge.com/en/news/279375378.md)
- [ZAWYA-SNG: Forbes names TMG Egypt’s top listed real estate developer for 2026](https://longbridge.com/en/news/279371980.md)
- [TABLE-Asian physical rubber prices - March 17](https://longbridge.com/en/news/279390955.md)